Retatrutide 10mg
Price range: $60.00 through $350.00
Triple Receptor Agonist — Most Effective for Fat Loss (24% Weight Reduction in Clinical Trials)
Source manufacturer
Direct LPPEPTIDE production and fulfillment.
Batch traceable
Batch ID and test date stay connected.
Securely packed
Packed for stable transit from our fulfillment flow.
| Attribute | Details |
|---|---|
| Product | LPPEPTIDE RT10 |
| Knowledge Source | Retatrutide (RT) |
| Specification | 10 mg × 10 vials per box |
| Category | Weight Loss & Metabolic |
| Research Focus | Weight Loss & Metabolic |
| Form | Lyophilized Powder |
| Reconstitution | LPPEPTIDE knowledge source: Add 1.0 mL bacteriostatic water to achieve an approximate concentration of 5.0 mg/mL. Reference range is 2–8 mg once weekly with gradual dose escalation over 8–12 weeks. At 5.0 mg/mL, 1 unit (U) on a U-100 insulin syringe is approximately 50 mcg. |
| Storage (Lyophilized) | Store at -20°C (-4°F) or below in a dry, dark environment. |
| Storage (Reconstituted) | Store at 2–8°C (36–46°F). Protect from light and use within approximately 4 weeks. Allow the sealed vial to reach room temperature before opening to minimize condensation. |
What is RT10?
Triple-receptor incretin agonist profile for metabolic research. The LPPEPTIDE knowledge record describes Retatrutide as an investigational GLP-1, GIP, and glucagon receptor agonist studied in obesity and type 2 diabetes models, with phase II research reporting high-dose body-weight reduction up to 24% over 48 weeks. Retatrutide 10mg is mapped to Lppeptide SKU RT10. Current storefront values use our product data: 10mg x 10 vials /box, $80.00 USD per box. Lppeptide reference specs: 5mg x 10 vials / 10mg x 10 vials / 15mg x 10 vials / 20mg x 10 vials / 30mg x 10 vials / 40mg x 10 vials / 60mg x 10 vials.
Research context
The LPPEPTIDE knowledge record describes Retatrutide as an investigational GLP-1, GIP, and glucagon receptor agonist studied in obesity and type 2 diabetes models, with phase II research reporting high-dose body-weight reduction up to 24% over 48 weeks. Research typically centers on GLP-1, GIP, and glucagon receptor signaling, with endpoints such as appetite signaling, glucose handling, and energy balance models.
Commonly matched with
RT10 is commonly reviewed alongside RT20, RT30, TR10, TR20, Tirzepatide. Keep each combination tied to a defined research objective and lot record.
Compliance notice
RT10 is supplied for research use only. It is not for human or veterinary use, not for consumption, and statements on this page are reference context rather than medical claims.
Reference literature focus
The LPPEPTIDE knowledge record describes Retatrutide as an investigational GLP-1, GIP, and glucagon receptor agonist studied in obesity and type 2 diabetes models, with phase II research reporting high-dose body-weight reduction up to 24% over 48 weeks. Research typically centers on GLP-1, GIP, and glucagon receptor signaling, with endpoints such as appetite signaling, glucose handling, and energy balance models.
Study design notes
Use the Lppeptide product knowledge record, current Lppeptide COA, and internal lab SOP to confirm identity, concentration, and endpoints before this material enters a study. The matched Lppeptide reference specification is 5mg x 10 vials / 10mg x 10 vials / 15mg x 10 vials / 20mg x 10 vials / 30mg x 10 vials / 40mg x 10 vials / 60mg x 10 vials.
Lppeptide handling reference
LPPEPTIDE knowledge source: add 1.0 mL bacteriostatic water for about 5.0 mg/mL. Reference range is once weekly 2-8 mg with gradual 8-12 week escalation. At 5.0 mg/mL, 1 U on a U-100 syringe is about 50 mcg.
LPPEPTIDE preparation pattern: use sterile technique, add diluent slowly down the vial wall, avoid foaming, roll gently until dissolved, label the preparation date, refrigerate at 2-8 deg C, and protect from light.
Preparation
Retatrutide 10mg ships as Lyophilized powder. Reconstitution note: LPPEPTIDE knowledge source: add 1.0 mL bacteriostatic water for about 5.0 mg/mL. Reference range is once weekly 2-8 mg with gradual 8-12 week escalation. At 5.0 mg/mL, 1 U on a U-100 syringe is about 50 mcg.. Record the final concentration and preparation date in the study log.
Storage
Lyophilized: -20 deg C or below, dry and dark. Reconstituted: 2-8 deg C, protect from light, use within about 4 weeks, and let the sealed vial reach room temperature before opening to reduce condensation.. Follow the most current lot-specific handling record whenever it is available.
Safety observations
Published discussion commonly focuses on gastrointestinal tolerance, hydration status, appetite-pathway effects, and limited long-term human safety data.
Contraindications
Do not use RT10 outside qualified research workflows. Review the current SDS, COA, and protocol exclusions before handling.
Interaction review
Use extra caution in models involving other incretin, glucose-lowering, appetite, or gastric-emptying pathways.
Certificate of Analysis
Each Lppeptide lot should be confirmed against current batch documentation before shipment or study use. This product page keeps RT10 visible so the SKU can be matched to the active COA.
Current catalog summary
- SKU: RT10
- Product: Retatrutide 10mg
- Storefront specification: 10mg x 10 vials /box
- Lppeptide reference specs: 5mg x 10 vials / 10mg x 10 vials / 15mg x 10 vials / 20mg x 10 vials / 30mg x 10 vials / 40mg x 10 vials / 60mg x 10 vials
- Listed box price: $80.00 USD
- Reference: Lppeptide product knowledge record
Testing checklist
- Peptide identity or material identity
- HPLC purity or assay result where applicable
- Batch ID and test date
- Sterility/endotoxin or accessory checks when applicable
- Residual solvent and handling notes where applicable
Q: Is RT10 sold for research use only?
A: RT10 is supplied by Lppeptide for qualified research use only. It is not for human or veterinary use, not for consumption, and local rules may vary by jurisdiction.
Q: Where do I confirm the current RT10 lot documentation?
A: Use the COA & Testing tab, product label, and current Lppeptide batch record to confirm SKU RT10, specification, identity, and handling details before research use.
Q: Can RT10 be reviewed with related products?
A: Yes, when the study protocol defines the rationale. Common comparison or stack candidates include RT20, RT30, TR10, TR20. Keep fixed-ratio blends and single-compound materials documented separately.
Q: Why can details differ from reference articles or catalog pages?
A: Reference pages provide general compound context. Lppeptide product pages should follow the current product record, active COA, lot-specific handling sheet, and lab SOP.
Direct catalog supply
Lppeptide product pages use our own SKU, package, price, and stock data first. Lppeptide knowledge mapping adds compound education, handling notes, and specification checks while lot-specific editorial content is being prepared.
Lot-specific content
For final release decisions, use the current product record, COA, handling sheet, and research SOP as the highest-priority source for this page.
Q: Is RT10 sold for research use only?
A: RT10 is supplied by Lppeptide for qualified research use only. It is not for human or veterinary use, not for consumption, and local rules may vary by jurisdiction.
Q: Where do I confirm the current RT10 lot documentation?
A: Use the COA & Testing tab, product label, and current Lppeptide batch record to confirm SKU RT10, specification, identity, and handling details before research use.
Q: Can RT10 be reviewed with related products?
A: Yes, when the study protocol defines the rationale. Common comparison or stack candidates include RT20, RT30, TR10, TR20. Keep fixed-ratio blends and single-compound materials documented separately.
Q: Why can details differ from reference articles or catalog pages?
A: Reference pages provide general compound context. Lppeptide product pages should follow the current product record, active COA, lot-specific handling sheet, and lab SOP.
| Dossage | 10mg*10vials, 15mg*10vials, 20mg*10vials 8, 30mg*10vials, 40mg*10vials 1, 5mg*10vials, 60mg*10vials |
|---|
Related products
Semaglutide
Tesamorelin 10mg
Tesamorelin 10mg (TS10) by LP Peptides is a premium lyophilized research peptide supplied in 10mg × 10 vials per box. As a synthetic Growth Hormone-Releasing Hormone (GHRH) analog, TS10 is widely studied in endocrine, metabolic, IGF-1, lipid metabolism, and growth hormone research. Produced with batch-specific quality documentation, it is intended exclusively for qualified laboratory research and not for human or veterinary use.
Tirzepatide 10mg
Tirzepatide 10mg (TR10) by LP Peptides is a premium lyophilized research peptide supplied in 10mg × 10 vials per box. As a dual GLP-1 and GIP receptor agonist, TR10 is widely studied in metabolic, obesity, glucose regulation, insulin signaling, appetite regulation, and endocrine research. Produced with batch-specific quality documentation, it is intended exclusively for qualified laboratory research and not for human or veterinary use.